Chapter 24: Heart Failure Drugs Flashcards

1
Q

What are the drug therapies for heart failure?

A
  • ACE inhibitors
  • Angiotensin II receptor blockers
  • Beta blockers
  • aldosterone antagonists
  • B-type natriuretic peptides
  • phosphodiesterase inhibitors
  • cardiac glycoside (digoxin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aldosterone antagonist

A

indicated for severe CHF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Spironolactone

A

potassium-sparing diuretic that has been shown to reduce CHF symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What drugs are considered aldosterone antagonists?

A

spironolactone and eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the miscellaneous drugs to treat heart failure?

A
  • hydralazine/isosorbide dinitrate

- dobutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hydralazine/isosorbide dinitrate

A

first drug approved for a specific ethnic group, namely african americans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dobutamine

A
  • beta1-selective vasoactive adrenergic drug

- structurally similar to dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

B-Type Natriuretic Peptides includes

A

Nesiritide (Natrecor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

nesiritide (natrecor)

A

used in the intensive care setting as a final effort to treat severe, life-threatening heart failure, often in combination with several other cardiostimulatory medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mechanism of action for B-Type Natriuretic Peptides

A
  • effects include diuresis (urinary fluid loss), natriuresis (urinary sodium loss) and vasodilation
  • vasodilating effects on both arteries and veins
  • indirectly increases cardiac output
  • suppresses renin-angiotensin system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phosphodiesterase Inhibitors

A

work by inhibiting the enzyme phosphodiesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Use of phosphodiesterase inhibitors results in

A

positive inotropic response and vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name a phosphodiesterase inhibitor

A

milrinone (primacor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the indications of phosphodiesterase inhibitors?

A
  • short-term management of heart failure
  • given when patient does not respond to treatment with digoxin, diuretics and/or vasodilators
  • American Heart Associations and American College of Cardiology advise against long term infusions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adverse Effects of the Phosphodiesterase inhibitor, Milrinone

A
  • dysrhythmia
  • hypotension
  • angina
  • hypokalemia
  • tremor
  • thrombocytopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cardiac Glycosides

A
  • from digitalis plant, foxglove
  • for heart failure and control ventricular response to atrial fibrillation or flutter
  • prototype is digoxin
17
Q

What is the mechanism of action for cardiac glycosides?

A
  • increase myocardial contractility
  • change electrical conduction properties of the heart: decrease rate of electrical conduction, prolong the refractory period (area between SA node and AV node)
18
Q

What are the drug effects of cardiac glycosides?

A
  • positive inotropic effect
  • negative chronotropic effect
  • negative dromotropic effect
19
Q

positive inotropic effect

A

increased force of myocardial contraction (without an increase in oxygen consumption)

20
Q

Negative chronotropic effect

A

reduces heart rate

21
Q

Negative dromotropic effect

A

decreases electrical conduction of heart

22
Q

What are indications for cardiac glycosides?

A
  • heart failure

- supraventricular dysrhythmias: atrial fibrillation and atrial flutter

23
Q

What are the cardiac glycosides?

A

digoxin and lanoxin

24
Q

Cardiac Glycosides: Digoxin and Lanoxin

A
  • very narrow therapeutic window
  • drug levels must be monitored: 0.5-2 ng/mL
  • electrolyte levels must be monitored
25
Q

What do low potassium levels do to the cardiac glycosides: digoxin and lanoxin?

A

low potassium levels increase its toxicity

26
Q

What are the adverse effects of cardiac glycosides?

A
  1. CV
  2. CNS
  3. Eyes
  4. GI
27
Q

What are the adverse effects on the cardiovascular system due to cardiac glycosides?

A

dysrhythmias, including bradycardia or tachycardia

28
Q

What are the adverse effects on the CNS due to cardiac glycosides?

A

headaches, fatigue, malaise, confusion, convulsions

29
Q

What are the adverse effects on the eyes due to cardiac glycosides?

A

colored vision (seeing green, yellow, purple), halo vision, flickering lights

30
Q

What are the adverse effects on the GI system due to cardiac glycosides?

A

Anorexia, nausea, vomiting and diarrhea

31
Q

Digoxin Toxicity

A
  • hyperkalemia (serum potassium greater than 5 mEq/L) in a digitalis toxic patient
  • life-threatening cardiac dysrhythmias
  • life-threatening digoxin overdose
32
Q

What is the antidote for digoxin toxicity?

A

digoxin immune Fab

33
Q

What are conditions that predispose digoxin toxicity?

A
  • hypokalemia, use of a pacemaker, liver disease, hypercalcemia
  • dysrhythmias, hypothyroid, respiratory, or renal disease, advanced age
34
Q

Nursing Diagnosis

A

discuss nursing diagnosis and patient-centered care pg 383-387

35
Q

inotropic

A

drugs that influence the force of muscular contractions, particularly contractions of the heart muscle

36
Q

chronotropic

A

drugs that influence the rate of the heartbeat

37
Q

dromotropic

A

drugs that influence the conduction of electrical impulses within the tissues